Big Pharma, allied with cutting-edge biotech companies and supported by governments, just delivered a modern scientific miracle: not one but multiple vaccines against Covid-19 — and in record time. This was a moonshot compressed into a few months, accelerated by unprecedented collaboration between rival pharma giants and featuring large numbers of female scientists — many of them immigrants. The victory could help incentivize big pharma to produce more medicines for all rather than pricey remedies for niche diseases. Bloomberg New Economy Editorial Director Andy Browne discusses with Mammoth Biosciences Co-founder & CTO, Janice Chen, BioNTech Senior Vice President Katalin Karikó and Chile's Undersecretary of International Economic Relations Rodrigo Yáñez.

Be the first to comment